Aenova Group Is A Prominent Global Contract Manufacturer And Development Services Provider For The Pharmaceutical And Healthcare Sectorsestablished In 2008 Through The Merger Of Dragenopharm And Swiss Capsaenova Has Grown Significantlywith Key Acquisitions Including The Temmler Group And Haupt Pharmaheadquartered Near Munichgermanythe Company Operates Multiple Sites Across Europe And The Usemploying Around 4 000 Staff Members Aenova Offers A Comprehensive Range Of Services That Cover The Entire Value Chain For Pharmaceuticals And Dietary Supplementsthis Includes End To End Manufacturing For Various Dosage Formsdevelopment Services To Prepare Products For Commercial Productionand A Strong Emphasis On Innovative Technologiesthe Company Produces A Wide Array Of Pharmaceutical Products For Both Human And Veterinary Marketsas Well As Dietary Supplements Aimed At Enhancing Health And Well Beingwith A Planned Turnover Of Approximately Eur 750 Millionaenova Is Recognized As A Leading Player In The Industrycommitted To High Quality Standards And Continuous Innovation
